Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP324443.RAp9UySFM1L7oXGpN2C_A1a4GZLrErAPAv7lx7AcYD7mA130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP324443.RAp9UySFM1L7oXGpN2C_A1a4GZLrErAPAv7lx7AcYD7mA130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP324443.RAp9UySFM1L7oXGpN2C_A1a4GZLrErAPAv7lx7AcYD7mA130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP324443.RAp9UySFM1L7oXGpN2C_A1a4GZLrErAPAv7lx7AcYD7mA130_provenance.
- befree-20150227 importedOn "2015-02-27" NP324443.RAp9UySFM1L7oXGpN2C_A1a4GZLrErAPAv7lx7AcYD7mA130_provenance.
- NP324443.RAp9UySFM1L7oXGpN2C_A1a4GZLrErAPAv7lx7AcYD7mA130_assertion wasGeneratedBy ECO_0000203 NP324443.RAp9UySFM1L7oXGpN2C_A1a4GZLrErAPAv7lx7AcYD7mA130_provenance.
- NP324443.RAp9UySFM1L7oXGpN2C_A1a4GZLrErAPAv7lx7AcYD7mA130_assertion wasDerivedFrom befree-20150227 NP324443.RAp9UySFM1L7oXGpN2C_A1a4GZLrErAPAv7lx7AcYD7mA130_provenance.
- NP324443.RAp9UySFM1L7oXGpN2C_A1a4GZLrErAPAv7lx7AcYD7mA130_assertion SIO_000772 11840259 NP324443.RAp9UySFM1L7oXGpN2C_A1a4GZLrErAPAv7lx7AcYD7mA130_provenance.
- NP324443.RAp9UySFM1L7oXGpN2C_A1a4GZLrErAPAv7lx7AcYD7mA130_assertion evidence source_evidence_literature NP324443.RAp9UySFM1L7oXGpN2C_A1a4GZLrErAPAv7lx7AcYD7mA130_provenance.
- NP324443.RAp9UySFM1L7oXGpN2C_A1a4GZLrErAPAv7lx7AcYD7mA130_assertion description "[Multivariate COX regression analysis adjusted for chemotherapy protocol, de novo vs secondary AML, and de novo vs relapsed AML indicated: (1) At diagnosis, high expression of Bad (P = 0.015) and even more so high Bax and Bad levels (P = 0.018) predicted adverse outcome, regardless of the response to ICT.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP324443.RAp9UySFM1L7oXGpN2C_A1a4GZLrErAPAv7lx7AcYD7mA130_provenance.